1. Home
  2. LASE vs CALC Comparison

LASE vs CALC Comparison

Compare LASE & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Laser Photonics Corporation

LASE

Laser Photonics Corporation

HOLD

Current Price

$2.73

Market Cap

62.7M

Sector

Industrials

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$4.66

Market Cap

63.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LASE
CALC
Founded
2019
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.7M
63.0M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
LASE
CALC
Price
$2.73
$4.66
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.50
AVG Volume (30 Days)
268.4K
120.5K
Earning Date
04-02-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,938,027.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
89.34
N/A
52 Week Low
$1.71
$1.42
52 Week High
$7.31
$4.82

Technical Indicators

Market Signals
Indicator
LASE
CALC
Relative Strength Index (RSI) 39.98 63.89
Support Level $2.70 $4.09
Resistance Level $3.06 $4.75
Average True Range (ATR) 0.22 0.41
MACD 0.01 0.00
Stochastic Oscillator 4.92 77.74

Price Performance

Historical Comparison
LASE
CALC

About LASE Laser Photonics Corporation

Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: